G.A. MacGibbon

1.1k total citations
17 papers, 985 citations indexed

About

G.A. MacGibbon is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, G.A. MacGibbon has authored 17 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in G.A. MacGibbon's work include Neuroscience and Neuropharmacology Research (10 papers), Alzheimer's disease research and treatments (6 papers) and Nuclear Receptors and Signaling (5 papers). G.A. MacGibbon is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Alzheimer's disease research and treatments (6 papers) and Nuclear Receptors and Signaling (5 papers). G.A. MacGibbon collaborates with scholars based in New Zealand, United States and Canada. G.A. MacGibbon's co-authors include Mike Dragunow, P. Lawlor, M. Walton, Ernest Sirimanne, Deborah Young, Paul E. Hughes, Peter D. Gluckman, R Bravo, Richard L. M. Faull and Michael Dragunow and has published in prestigious journals such as Journal of Molecular Biology, Brain Research and Experimental Neurology.

In The Last Decade

G.A. MacGibbon

17 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.A. MacGibbon New Zealand 15 532 447 220 127 112 17 985
Susan D. Craddock United States 11 434 0.8× 324 0.7× 313 1.4× 210 1.7× 107 1.0× 14 933
Jeffrey W. Horn United States 9 435 0.8× 358 0.8× 148 0.7× 121 1.0× 48 0.4× 15 837
Christophe Crochemore Italy 15 365 0.7× 299 0.7× 148 0.7× 146 1.1× 103 0.9× 16 1.1k
Karin Werrbach‐Perez United States 21 603 1.1× 669 1.5× 245 1.1× 135 1.1× 172 1.5× 43 1.3k
Frédéric Dessi France 15 543 1.0× 499 1.1× 157 0.7× 142 1.1× 61 0.5× 23 927
Tiina Kotti Finland 15 726 1.4× 383 0.9× 195 0.9× 85 0.7× 54 0.5× 16 1.3k
Lorene M. Leiter United States 7 534 1.0× 303 0.7× 419 1.9× 196 1.5× 71 0.6× 8 1.2k
Petar Podlesniy Spain 17 520 1.0× 292 0.7× 290 1.3× 143 1.1× 131 1.2× 29 922
Jee-Yeon Hwang United States 17 905 1.7× 361 0.8× 152 0.7× 208 1.6× 146 1.3× 24 1.5k
Izabela Figiel Poland 19 506 1.0× 352 0.8× 175 0.8× 240 1.9× 53 0.5× 35 1.1k

Countries citing papers authored by G.A. MacGibbon

Since Specialization
Citations

This map shows the geographic impact of G.A. MacGibbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.A. MacGibbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.A. MacGibbon more than expected).

Fields of papers citing papers by G.A. MacGibbon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.A. MacGibbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.A. MacGibbon. The network helps show where G.A. MacGibbon may publish in the future.

Co-authorship network of co-authors of G.A. MacGibbon

This figure shows the co-authorship network connecting the top 25 collaborators of G.A. MacGibbon. A scholar is included among the top collaborators of G.A. MacGibbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.A. MacGibbon. G.A. MacGibbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pearson, Andree G., et al.. (2006). Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Neuroscience Letters. 398(3). 246–250. 45 indexed citations
2.
MacGibbon, G.A., Lorraine C. Hamilton, Susan Crocker, et al.. (2002). Immediate‐early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice. Journal of Neuroscience Research. 67(3). 372–378. 21 indexed citations
3.
Zhang, Shaoping, et al.. (2002). Increased Expression and Activation of c-Jun Contributes to Human Amylin-induced Apoptosis in Pancreatic Islet β-Cells. Journal of Molecular Biology. 324(2). 271–285. 58 indexed citations
4.
Dragunow, Michael, Ruian Xu, M. Walton, et al.. (2000). c-Jun promotes neurite outgrowth and survival in PC12 cells. Molecular Brain Research. 83(1-2). 20–33. 64 indexed citations
5.
Walton, M., Hannah M. Gibbons, G.A. MacGibbon, et al.. (2000). PU.1 expression in microglia. Journal of Neuroimmunology. 104(2). 109–115. 55 indexed citations
6.
Walton, M., et al.. (1999). Inducible transcription factor expression in a cell culture model of apoptosis. Molecular Brain Research. 66(1-2). 211–216. 13 indexed citations
7.
MacGibbon, G.A., et al.. (1999). The toxicity of 6-hydroxydopamine on PC12 and P19 cells. Molecular Brain Research. 69(1). 84–92. 67 indexed citations
8.
Walton, M., G.A. MacGibbon, Deborah Young, et al.. (1998). Do c-Jun, c-Fos, and amyloid precursor protein play a role in neuronal death or survival?. Journal of Neuroscience Research. 53(3). 330–342. 28 indexed citations
9.
Walton, M., Josep Saura, Deborah Young, et al.. (1998). CCAAT-enhancer binding proteinα is expressed in activated microglial cells after brain injury. Molecular Brain Research. 61(1-2). 11–22. 25 indexed citations
10.
Dragunow, Mike, G.A. MacGibbon, P. Lawlor, et al.. (1997). Apoptosis, Neurotrophic Factors and Neurodegeneration. Reviews in the Neurosciences. 8(3-4). 223–65. 44 indexed citations
11.
Saura, Josep, G.A. MacGibbon, & Mike Dragunow. (1997). Etoposide-induced PC12 cell death: apoptotic morphology without oligonucleosomal DNA fragmentation or dependency upon de novo protein synthesis. Molecular Brain Research. 48(2). 382–388. 15 indexed citations
12.
MacGibbon, G.A., P. Lawlor, Ernest Sirimanne, et al.. (1997). Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Research. 750(1-2). 223–234. 123 indexed citations
13.
MacGibbon, G.A., P. Lawlor, M. Walton, et al.. (1997). Expression of Fos, Jun, and Krox Family Proteins in Alzheimer's Disease. Experimental Neurology. 147(2). 316–332. 71 indexed citations
14.
MacGibbon, G.A., Garth J. S. Cooper, & Michael Dragunow. (1997). Acute application of human amylin, unlike β-amyloid peptides, kills undifferentiated PC12 cells by apoptosis. Neuroreport. 8(18). 3945–3949. 10 indexed citations
15.
MacGibbon, G.A., P. Lawlor, Paul E. Hughes, Deborah Young, & Mike Dragunow. (1995). Differential expression of inducible transcription factors in basal ganglia neurons. Molecular Brain Research. 34(2). 294–302. 21 indexed citations
16.
MacGibbon, G.A., P. Lawlor, R Bravo, & Mike Dragunow. (1994). Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Molecular Brain Research. 23(1-2). 21–32. 135 indexed citations
17.
Dragunow, Mike, Deborah Young, Paul E. Hughes, et al.. (1993). Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury?. Molecular Brain Research. 18(4). 347–352. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan D. Craddock Breakdown of academic impact, for papers by Jeffrey W. Horn Breakdown of academic impact, for papers by Christophe Crochemore Breakdown of academic impact, for papers by Karin Werrbach‐Perez Breakdown of academic impact, for papers by Frédéric Dessi Breakdown of academic impact, for papers by Tiina Kotti Breakdown of academic impact, for papers by Lorene M. Leiter Breakdown of academic impact, for papers by Petar Podlesniy Breakdown of academic impact, for papers by Jee-Yeon Hwang Breakdown of academic impact, for papers by Izabela Figiel
Rankless by CCL
2026